Integer (NYSE:ITGR) PT Raised to $124.00

Integer (NYSE:ITGR) had its price target increased by investment analysts at Citigroup from $118.00 to $124.00 in a research note issued on Wednesday, Benzinga reports. The firm presently has a “neutral” rating on the medical equipment provider’s stock. Citigroup’s price target suggests a potential upside of 1.78% from the company’s current price.

ITGR has been the topic of several other reports. Truist Financial started coverage on shares of Integer in a research report on Wednesday, May 15th. They issued a “buy” rating and a $137.00 price target on the stock. Bank of America raised shares of Integer from a “neutral” rating to a “buy” rating and raised their price target for the stock from $105.00 to $135.00 in a research note on Monday, April 15th. CL King began coverage on shares of Integer in a research report on Thursday, March 14th. They issued a “buy” rating and a $137.00 price objective for the company. Benchmark reaffirmed a “buy” rating and issued a $130.00 target price on shares of Integer in a research note on Friday, May 10th. Finally, KeyCorp increased their price target on Integer from $123.00 to $139.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 9th. Three analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $128.00.

Integer Stock Up 0.2 %

ITGR opened at $121.83 on Wednesday. Integer has a 52 week low of $69.40 and a 52 week high of $123.99. The business has a 50 day moving average price of $115.56 and a two-hundred day moving average price of $104.80. The company has a quick ratio of 2.01, a current ratio of 3.32 and a debt-to-equity ratio of 0.76. The company has a market cap of $4.08 billion, a PE ratio of 42.16, a P/E/G ratio of 1.79 and a beta of 1.12.

Integer (NYSE:ITGR) last issued its earnings results on Thursday, April 25th. The medical equipment provider reported $1.14 earnings per share for the quarter, beating the consensus estimate of $1.12 by $0.02. The business had revenue of $414.80 million for the quarter, compared to the consensus estimate of $412.78 million. Integer had a net margin of 6.01% and a return on equity of 11.25%. The business’s quarterly revenue was up 9.5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.87 earnings per share. As a group, research analysts anticipate that Integer will post 5.27 EPS for the current year.

Insider Buying and Selling

In other news, EVP John A. Harris sold 312 shares of the business’s stock in a transaction that occurred on Tuesday, May 7th. The stock was sold at an average price of $113.00, for a total transaction of $35,256.00. Following the completion of the transaction, the executive vice president now directly owns 1,157 shares in the company, valued at $130,741. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, EVP John A. Harris sold 312 shares of the business’s stock in a transaction that occurred on Tuesday, May 7th. The stock was sold at an average price of $113.00, for a total transaction of $35,256.00. Following the sale, the executive vice president now owns 1,157 shares of the company’s stock, valued at $130,741. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, VP Tommy P. Thomas sold 1,500 shares of Integer stock in a transaction on Tuesday, April 30th. The shares were sold at an average price of $114.00, for a total value of $171,000.00. Following the transaction, the vice president now owns 2,813 shares in the company, valued at $320,682. The disclosure for this sale can be found here. Insiders sold a total of 6,812 shares of company stock worth $771,956 in the last three months. 2.00% of the stock is owned by insiders.

Institutional Investors Weigh In On Integer

A number of large investors have recently made changes to their positions in ITGR. Virtu Financial LLC bought a new position in shares of Integer during the 1st quarter valued at $298,000. Hancock Whitney Corp acquired a new stake in shares of Integer in the first quarter worth about $203,000. Price T Rowe Associates Inc. MD increased its holdings in shares of Integer by 6.8% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 19,031 shares of the medical equipment provider’s stock valued at $2,221,000 after acquiring an additional 1,219 shares during the last quarter. Gamco Investors INC. ET AL raised its stake in shares of Integer by 3.0% in the 1st quarter. Gamco Investors INC. ET AL now owns 29,432 shares of the medical equipment provider’s stock valued at $3,434,000 after acquiring an additional 850 shares in the last quarter. Finally, Pitcairn Co. boosted its position in Integer by 11.2% during the first quarter. Pitcairn Co. now owns 6,427 shares of the medical equipment provider’s stock worth $750,000 after purchasing an additional 649 shares during the period. Institutional investors and hedge funds own 99.29% of the company’s stock.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.